Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · Registration

AGIOS PHARMACEUTICALS

via AGIOS PHARMACEUTICALS

2nd Quarter (Apr 1 - June 30) · 2025Posted Jun 12, 2025Filing document ↗LDA record ↗

Coverage · Registration filing — establishes the registrant/client relationship. No periodic income or expenses are reported at registration.

Client

Name: AGIOS PHARMACEUTICALS
Description: Pharmacy, Medicare/Medicaid, Health Issues
Location: Massachusetts · United States of America

Registrant

Firm: AGIOS PHARMACEUTICALS
Location: Cambridge, Massachusetts, United States of America

Lobbying activities

3 issues

Pharmacy
Pharmacy, Medicare/Medicaid, Health Issues
LobbyistsAARON KRUPP
Medicare/Medicaid
Pharmacy, Medicare/Medicaid, Health Issues
LobbyistsAARON KRUPP
Health Issues
Pharmacy, Medicare/Medicaid, Health Issues
LobbyistsAARON KRUPP

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

AGIOS PHARMACEUTICALS — Lobbying — Receipts Report